Reader View AI Reader View 60 Degrees Pharmaceuticals receives Nasdaq delisting notice, plans reverse split www.investing.com · November 20, 2026 · 23:04 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link